APA

Hill A., Ridley S. H., Esser D., Oldroyd R. G., Cullen M. J., Kareclas P., Gallagher S., Smith G. P., Richards S. J., White J., Smith R. A. G. & Hillmen P. (20060403). Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy. : Blood.

Chicago

Hill Anita, Ridley Simon H, Esser Dirk, Oldroyd Rodney G, Cullen Matthew J, Kareclas Paula, Gallagher Seán, Smith Geoffrey P, Richards Stephen J, White Jennifer, Smith Richard A G and Hillmen Peter. 20060403. Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy. : Blood.

Harvard

Hill A., Ridley S. H., Esser D., Oldroyd R. G., Cullen M. J., Kareclas P., Gallagher S., Smith G. P., Richards S. J., White J., Smith R. A. G. and Hillmen P. (20060403). Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy. : Blood.

MLA

Hill Anita, Ridley Simon H, Esser Dirk, Oldroyd Rodney G, Cullen Matthew J, Kareclas Paula, Gallagher Seán, Smith Geoffrey P, Richards Stephen J, White Jennifer, Smith Richard A G and Hillmen Peter. Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy. : Blood. 20060403.